Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,800 | 9 | 70.6% |
| Food and Beverage | $8,489 | 253 | 27.5% |
| Education | $584.81 | 9 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $22,555 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $1,187 | 40 | $0 (2024) |
| ABBVIE INC. | $1,035 | 45 | $0 (2024) |
| Lilly USA, LLC | $957.55 | 25 | $0 (2024) |
| GENZYME CORPORATION | $597.63 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $459.12 | 14 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $402.86 | 7 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $391.95 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $388.40 | 18 | $0 (2024) |
| Almirall LLC | $370.94 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,505 | 51 | Galderma Laboratories, L.P. ($9,848) |
| 2023 | $13,843 | 52 | Galderma Laboratories, L.P. ($12,355) |
| 2022 | $1,047 | 27 | Galderma Laboratories, L.P. ($185.08) |
| 2021 | $802.16 | 40 | AbbVie Inc. ($167.94) |
| 2020 | $568.37 | 23 | Allergan, Inc. ($146.44) |
| 2019 | $1,332 | 37 | Helsinn Therapeutics (U.S.), Inc. ($174.05) |
| 2018 | $927.45 | 9 | Ortho Dermatologics, a division of Bausch Health US, LLC ($227.68) |
| 2017 | $848.59 | 32 | LEO Pharma Inc. ($164.21) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation & Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: ACNE | ||||||
| 11/13/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: ACNE | ||||||
| 10/16/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: ACNE | ||||||
| 10/16/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.19 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $44.38 | General |
| 10/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $9.48 | General |
| 10/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: DERMATOLOGY | ||||||
| 09/25/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $62.98 | General |
| 09/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $88.68 | General |
| 09/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Dermatology | ||||||
| 08/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $89.47 | General |
| 08/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,259 | 4,549 | $595,023 | $198,388 |
| 2022 | 16 | 2,141 | 4,279 | $543,751 | $180,109 |
| 2021 | 16 | 1,761 | 3,291 | $422,484 | $143,373 |
| 2020 | 15 | 1,792 | 3,793 | $428,665 | $141,742 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 574 | 1,013 | $177,433 | $60,041 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 385 | $95,030 | $32,786 | 34.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 316 | 389 | $76,679 | $26,238 | 34.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 324 | 521 | $68,002 | $20,226 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 217 | 217 | $47,097 | $14,897 | 31.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 245 | 1,553 | $25,251 | $7,730 | 30.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 70 | 91 | $20,086 | $7,125 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $17,807 | $5,964 | 33.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 95 | 150 | $14,686 | $5,731 | 39.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 36 | $11,832 | $4,382 | 37.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 27 | $9,404 | $3,320 | 35.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 13 | 14 | $8,253 | $2,904 | 35.2% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 11 | 11 | $5,650 | $2,241 | 39.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 19 | 20 | $4,892 | $1,704 | 34.8% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 27 | 27 | $4,755 | $1,226 | 25.8% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $4,000 | $800.28 | 20.0% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 14 | $2,630 | $636.64 | 24.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $1,537 | $437.40 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 579 | 987 | $174,584 | $59,966 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 352 | $88,016 | $32,017 | 36.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 298 | 358 | $72,122 | $23,751 | 32.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 319 | 478 | $62,799 | $18,397 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 190 | 190 | $41,435 | $11,795 | 28.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 244 | 1,539 | $25,460 | $7,401 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $18,246 | $5,935 | 32.5% |
About Dr. Ana Sauceda, M.D
Dr. Ana Sauceda, M.D is a Dermatology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497764302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ana Sauceda, M.D has received a total of $30,874 in payments from pharmaceutical and medical device companies, with $11,505 received in 2024. These payments were reported across 271 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,800).
As a Medicare-enrolled provider, Sauceda has provided services to 7,953 Medicare beneficiaries, totaling 15,912 services with total Medicare billing of $663,612. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Internal Medicine
- Location San Antonio, TX
- Active Since 08/07/2006
- Last Updated 01/23/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497764302
Products in Payments
- AKLIEF (Drug) $9,648
- TREMFYA (Drug) $1,287
- TALTZ (Drug) $706.48
- DUPIXENT (Biological) $641.19
- SKYRIZI (Biological) $430.84
- SILIQ (Drug) $319.55
- DUPIXENT DUPILUMAB INJECTION (Biological) $275.10
- Otezla (Drug) $268.79
- Tremfya (Drug) $243.78
- COSENTYX (Drug) $228.83
- Seysara (Drug) $225.57
- ENSTILAR (Drug) $206.46
- CIBINQO (Drug) $202.87
- Humira (Biological) $196.08
- VALCHLOR (Drug) $174.05
- COSENTYX (Biological) $159.57
- VTAMA (Drug) $156.54
- EPIDUO FORTE (Drug) $149.16
- ADBRY (Biological) $144.85
- ZEPBOUND (Drug) $123.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Antonio
Dr. William Cragun, M.d, M.D
Dermatology — Payments: $1.9M
Emily Becker, M.d, M.D
Dermatology — Payments: $937,773
Dr. Mark Lee, M.d, M.D
Dermatology — Payments: $589,973
Dr. Lindsey Finklea, M.d, M.D
Dermatology — Payments: $265,879
Steven Davis, Md, MD
Dermatology — Payments: $114,713
Stephen Miller, M.d. P.a, M.D. P.A
Dermatology — Payments: $89,896